Mark Hertzberg

Mark Hertzberg

UNVERIFIED PROFILE

Are you Mark Hertzberg?   Register this Author

Register author
Mark Hertzberg

Mark Hertzberg

Publications by authors named "Mark Hertzberg"

Are you Mark Hertzberg?   Register this Author

70Publications

1852Reads

28Profile Views

Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation.

Br J Haematol 2019 Oct 6. Epub 2019 Oct 6.

BC Cancer Centre for Lymphoid Cancer and the University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16201DOI Listing
October 2019

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety.

J Clin Oncol 2018 08 1;36(23):2395-2404. Epub 2018 Jun 1.

Wolfgang Hiddemann and Roswitha Forstpointner, University Hospital, Ludwig Maximilian University Munich, Munich; Jan Dürig, University Hospital Essen, Essen; Michael Herold, HELIOS-Klinikum Erfurt, Erfurt, Germany; Anna Maria Barbui, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy; Miguel A. Canales, Hospital Universitario la Paz, Madrid, Spain; Paul K. Cannell, Fiona Stanley Hospital, Murdoch, Western Australia; Mark Hertzberg, Prince of Wales Hospital; Judith Trotman, Concord Repatriation General Hospital, University of Sydney, Sydney, New South Wales; John F. Seymour, Royal Melbourne Hospital, and University of Melbourne, Melbourne, Victoria, Australia; Graham P. Collins, Churchill Hospital, Oxford; John Radford, University of Manchester and the Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester; Robert E. Marcus, Kings College Hospital, London, United Kingdom; Magdalena Klanova, Charles University General Hospital, Prague, Czech Republic; Magdalena Klanova, Alis Burciu, Günter Fingerle-Rowson, Marcel Wolbers, and Tina Nielsen, F. Hoffmann-La Roche, Basel, Switzerland; and Kensei Tobinai, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8960DOI Listing
August 2018

High-risk DLBCL: interim PET? Not yet.

Authors:
Mark Hertzberg

Blood 2017 09;130(11):1277-1278

PRINCE OF WALES HOSPITAL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-07-797381DOI Listing
September 2017

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

J Clin Oncol 2017 May 3;35(15):1678-1685. Epub 2017 Apr 3.

Kenneth F. Bradstock and Warwick Benson, Westmead Hospital, University of Sydney; Arno Enno, Sandra Deveridge, and Philip Rowlings, Calvary Mater Newcastle Hospital, Newcastle; Luke Coyle, Royal North Shore Hospital, St Leonards; Campbell Tiley, Central Coast Health, Gosford; John Moore, St Vincent's Hospital; Mark Hertzberg, Prince of Wales Hospital, Sydney; Kimberly Cartwright, Wollongong Hospital, Wollongong; Ilona Cunningham, Concord Repatriation General Hospital, Concord; John Taper, Nepean Hospital, Penrith, New South Wales; Emma Link, Juliana Di Iulio, and John F. Seymour, Peter MacCallum Cancer Centre; Jeff Szer, Andrew Grigg, Andrew W. Roberts, and John F. Seymour, University of Melbourne; Andrew H. Wei, Monash University; Anthony Schwarer, Box Hill Hospital; Lynda Campbell, Victorian Cancer Cytogenetics Service, Melbourne; Jeff Szer, Andrew Grigg, and Andrew W. Roberts, Royal Melbourne Hospital, Parkville; Phillip Campbell, Deakin University School of Medicine, Geelong, Victoria; Paula Marlton, Anthony K. Mills, and Devinder Gill, University of Queensland, Brisbane, Queensland; Ray M. Lowenthal, University of Tasmania, Hobart, Tasmania; Ian D. Lewis and Peter Bardy, Royal Adelaide Hospital; Uwe Hahn, Queen Elizabeth Hospital, Adelaide, South Australia; James D'Rozario, The Canberra Hospital, Garran, Canberra, Australia Capital Territory; Gavin Cull, Sir Charles Gairdner Hospital; Michael F. Leahy, University of Western Australia; and Paul Cannell, Royal Perth Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.6374
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.6374DOI Listing
May 2017

What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia.

Biol Blood Marrow Transplant 2016 04 30;22(4):731-743. Epub 2015 Dec 30.

Northern Clinical School, Faculty of Medicine, University of Sydney, Sydney, New South Wales, Australia; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia; Northern Blood Research Centre, Kolling Institute, University of Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.12.019DOI Listing
April 2016

Quantum Gravitational Force Between Polarizable Objects.

Phys Rev Lett 2016 04 15;116(15):151301. Epub 2016 Apr 15.

Institute of Cosmology, Department of Physics and Astronomy, Tufts University, Medford, Massachusetts 02155, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevLett.116.151301DOI Listing
April 2016

Gemcitabine and vinorelbine treatment in cutaneous T-cell lymphoma in four patients.

Australas J Dermatol 2015 Nov 13;56(4):294-7. Epub 2014 Dec 13.

Department of Dermatology, Westmead Hospital, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajd.12270DOI Listing
November 2015

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.

Lancet Haematol 2015 Oct 1;2(10):e445-55. Epub 2015 Oct 1.

University of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Brisbane, QLD, Australia; Princess Alexandra Hospital, Brisbane, QLD, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(15)00150-7DOI Listing
October 2015

Chronic lymphocytic leukaemia, monoclonal B-lymphocytosis and pregnancy: five cases, a literature review and discussion of management.

Br J Haematol 2015 Feb 25;168(3):350-60. Epub 2014 Sep 25.

Department of Haematology, Royal North Shore Hospital, St Leonards, Sydney, NSW, Australia; Kolling Institute, University of Sydney, St Leonards, Sydney, NSW, Australia; Chronic Lymphocytic Leukaemia Australian Research Consortium (CLLARC), Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13134DOI Listing
February 2015

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.

Blood 2015 Feb 17;125(6):915-23. Epub 2014 Dec 17.

Department of Haematology, and Discipline of Medicine, School of Medicine, University of Adelaide, Adelaide, Australia; Australasian Leukemia and Lymphoma Group, Melbourne, Australia; Cancer Theme, South Australia Health and Medical Research Institute, Adelaide, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-07-590315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161008PMC
February 2015

Relapsed/refractory Hodgkin lymphoma: what is the best salvage therapy and do we need RIC-alloSCT?

Authors:
Mark Hertzberg

Hematol Oncol Clin North Am 2014 Feb;28(1):123-47

Department of Haematology, Level 2 ICPMR, Westmead Hospital, Darcy Road, Westmead, New South Wales 2145, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2013.09.001DOI Listing
February 2014

Oscillons after inflation.

Phys Rev Lett 2012 Jun 14;108(24):241302. Epub 2012 Jun 14.

Department of Physics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevLett.108.241302DOI Listing
June 2012

Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP.

Pathology 2012 Apr;44(3):240-7

Royal College of Pathologists of Australasia (RCPA) Haematology Quality Assurance Program (QAP), Northmead, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0b013e32834d7b83DOI Listing
April 2012

Some calculable contributions to entanglement entropy.

Phys Rev Lett 2011 Feb 4;106(5):050404. Epub 2011 Feb 4.

Center for Theoretical Physics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevLett.106.050404DOI Listing
February 2011

The Clinical Impact of Infection with Swine Flu (H1N109) Strain of Influenza Virus in Hematopoietic Stem Cell Transplant Recipients.

Biol Blood Marrow Transplant 2011 Jan 15;17(1):147-53. Epub 2010 Jul 15.

Department of Haematology, Level II ICPMR, Westmead Hospital, Westmead, NSW 2145, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2010.07.004DOI Listing
January 2011

Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma.

Clin Cancer Res 2009 Jan;15(2):714-22

Clinical Haematology/Bone Marrow Transplant Department, The Alfred Hospital, Commercial Road, Prahran, Melbourne, Victoria, Australia 3181.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1022DOI Listing
January 2009

Melting of persistent double-stranded polymers.

Phys Rev E Stat Nonlin Soft Matter Phys 2008 Nov 12;78(5 Pt 1):051910. Epub 2008 Nov 12.

Department of Physics, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1103/PhysRevE.78.051910DOI Listing
November 2008

Optimizing fusion transcript monitoring in CML.

Blood 2007 Mar;109(5):2263; author reply 2263-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-08-043588DOI Listing
March 2007

Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates.

Lab Hematol 2005 ;11(2):91-7

Department of Haematology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://cardenjennings.metapress.com/openurl.asp?genre=articl
Publisher Site
http://dx.doi.org/10.1532/LH96.04063DOI Listing
October 2005

Nephrotic syndrome after stem cell transplantation.

Clin Transplant 2005 Feb;19(1):141-4

Department of Haematology, University of Sydney, Westmead Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1399-0012.2004.00294.xDOI Listing
February 2005

Genetic testing for thrombophilia mutations.

Authors:
Mark S Hertzberg

Semin Thromb Hemost 2005 Feb;31(1):33-8

Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2005-863803DOI Listing
February 2005

External quality assurance of DNA testing for thrombophilia mutations.

Am J Clin Pathol 2005 Feb;123(2):189-93

Department of Haematology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Australia.

View Article

Download full-text PDF

Source
February 2005

Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2002 ;8(9):501-11

Westmead Institute for Cancer Research, Westmead Millennium Institute, University of Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/bbmt.2002.v8.pm12374455DOI Listing
June 2003

Laboratory diagnosis of von Willebrand disorder. Current practice in the southern hemisphere.

Am J Clin Pathol 2003 Jun;119(6):882-93

Department of Haematology, RCPA Quality Assurance Program, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/8WVA-NM7H-0DKT-GB9FDOI Listing
June 2003

Stage IV CD30+ anaplastic large cell lymphoma: response to acitretin and interferon-alpha.

Australas J Dermatol 2002 Aug;43(3):207-10

Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1440-0960.2002.00597.xDOI Listing
August 2002

Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.

Am J Clin Pathol 2002 Aug;118(2):269-76

Haemostasis Laboratory, Haematology Division, Institute of Medical and Veterinary Science, University of South Australia, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/2D6F-RR03-8EFN-28F5DOI Listing
August 2002